MedPath

Thickness-Varied Soft Surface on Shoe-Insoles Based on In-Shoe Pressure Measurement

Not Applicable
Completed
Conditions
Diabetes Mellitus
Registration Number
NCT06679192
Lead Sponsor
Vastra Gotaland Region
Brief Summary

The goal of this cross-sectional study is to evaluate a new shoe insole manufacturing method with the goal of further preventing foot ulceration for people with diabetes. This is achieved by decreasing pressure under risk areas of the foot, often on the insole; the interface between the shoe and the foot. The main question it aims to answer is:

Does a thickness-varied surface based on plantar pressure measurement decrease pressure at high risk areas compared to even thickness surfaces.

Researchers will compare three different pairs of insoles for each participant.

Participants will partake in two sessions. The first one being a pre-measurement and foot status for manufacturing the insoles. During the second session, three pairs of insoles will in a random order be tested for each participant. The pressure measurement of the insoles will be made using F-Scan(TM), while participants walk.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Over 18 years of age at the date of signing consent.
  • Diabetes mellitus 1 or 2
  • Diabetic foot risk group 2: Signs of distal neuropathy and/or peripheral circulatory disorder.
  • Able to walk 10 meters without walking aids
  • Able to speak and understand Swedish
Exclusion Criteria
  • Diabetic foot risk group 3: Distal neuropathy or peripheral circulatory disorder and foot ulcers, or amputation, foot deformity of clinical importance or skin pathology.
  • Diabetic foot risk group 4: Occuring foot ulcer, severe osteoarthropathy or chronic foot pain.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Plantar pressurePre-measurement used for insole design at first meeting. Intervention-measurement for all patients and interventions at second meeting, approximately 3-4 weeks after pre-measurement.

Measured plantar pressure (kPa) differences between the arms/interventions.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

TeamOlmed Hagaplan

🇸🇪

Stockholm, Sweden

TeamOlmed Hagaplan
🇸🇪Stockholm, Sweden
© Copyright 2025. All Rights Reserved by MedPath